LISA OSTROWSKI: Open Payments
NPI 1881853786 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,437 in 298 payments from 25 companies in 2025. Trend: 2023 $29,697 · 2024 $6,337 · 2025 $5,437
Food & beverage: $5,128Honoraria: $178Education: $131
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 34 | $620 |
| UCB, Inc. | 20 | $574 |
| ABBVIE INC. | 26 | $497 |
| Janssen Biotech, Inc. | 26 | $497 |
| Regeneron Healthcare Solutions, Inc. | 20 | $450 |
| Paratek Pharmaceuticals, Inc. | 21 | $348 |
| GENZYME CORPORATION | 13 | $331 |
| Incyte Corporation | 20 | $290 |
| Arcutis Biotherapeutics, Inc. | 24 | $249 |
| Organon LLC | 21 | $234 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, TREMFYA, NUZYRA, OPZELURA, RINVOQ, Zoryve.
Industry payments across TX — which companies pay providers there.
